Oxxon Therapeutics oxti.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1133)

Oxxon Therapeutics is a mid-stage biotechnology company developing a portfolio of immunotherapeutics for infectious disease and cancer in man using its proprietary Heterologous PrimeBoost approach. The Company, incorporated in 1999, has already successfully progressed its products for the treatment of melanoma and hepatitis B to Phase II clinical trials, and has a number of pre-clinical products in development on its own or through collaborations.

Oxxon Therapeutics is a mid-stage biotechnology company developing a portfolio of immunotherapeutics for infectious disease and cancer in man using its proprietary Heterologous PrimeBoost approach. The Company, incorporated in 1999, has already succe...Show all

Company (Acquired)

Phone:

Fax:



Oxford,
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Oxxon Therapeutics $23.3M Mar 12, 2007

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Oxxon Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods and reagents for immunization which generate a cd8 t cell immune response Apr 28, 2004 Apr 07, 2009 Patent